Buto Corp
Home
About Us
Pipeline
Contact Us
Pitchdecks
  • Lung Fibrosis
  • Liver Fibrosis
Buto Corp
Home
About Us
Pipeline
Contact Us
Pitchdecks
  • Lung Fibrosis
  • Liver Fibrosis
More
  • Home
  • About Us
  • Pipeline
  • Contact Us
  • Pitchdecks
    • Lung Fibrosis
    • Liver Fibrosis
  • Home
  • About Us
  • Pipeline
  • Contact Us
  • Pitchdecks
    • Lung Fibrosis
    • Liver Fibrosis

Lung and liver anti-fibrotics

Anti-inflammatories for Neurodegenerative disease

Learn More

Lung and liver anti-fibrotics

Anti-inflammatories for Neurodegenerative disease

Learn More

Bringing Change to fibrotic disease

Buto has a unique therapeutic focus, to block inflammation of the innate immune system that drives fibrosis and AD.


Our molecules ameliorate human and mouse lung and liver fibrosis.

Our Target - the Shc protein

Buto's molecules uniquely inhibit the Shc protein and pathway. Shc expression and activity rises in fibrosis.

Further Questions?

Please visit our contact page for any questions or inquiries.

Find out more

Copyright © 2025 Buto Corp - all rights reserved.

  • Home
  • About Us
  • Pipeline
  • Contact Us
  • Lung Fibrosis
  • Liver Fibrosis

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept